Darren Riddy

Darren Riddy is a Senior Research Fellow in the Drug Discovery Biology department at Monash University, Australia. He has a strong interdisciplinary background in pharmacology and drug discovery with over two decades of experience across academic, pharmaceutical, and biotech sectors. His research is centered on G protein-coupled receptors (GPCRs), particularly their roles in inflammation and metabolic diseases.

His primary research interests include:

• G Protein-Coupled Receptors (GPCRs)
• Inflammation and its resolution
• Metabolic diseases such as type 2 diabetes
• Drug discovery targeting orphan and specialized pro-resolving mediator receptors

Darren’s recent publications highlight a consistent focus on the pharmacological characterization of GPCRs involved in metabolic regulation and inflammation resolution. His work spans from molecular and cellular pharmacology to translational models, with a strong emphasis on identifying novel therapeutic targets. Key themes across his publications include the role of GPR21 in glucose homeostasis, M4 muscarinic receptors in alcohol use disorder, and specialized pro-resolving mediators in chronic inflammation.

He has received several scientific awards, including:

• Best Student Poster Presentation Prize (2016, MPGPCR)
• Novartis Prize for selected abstracts from younger members (2010)
• Catalyst and Spot Awards (2008)
• Biodeterioration Centre Prize (2001)

Darren is actively involved in the academic community through peer review and grant evaluation. He has served as a reviewer for journals such as ACS Chemical Neuroscience and Journal of Medicinal Chemistry, and for grant panels like the Early Career Small Grant and Sonata-16. While he collaborates extensively, there is no public record of formal student supervision. He is not retired and remains an active research fellow at Monash University.